Rare liver disorder drug from Jazz wins U.S. approval
0
(Reuters) - The U.S. Food and Drug Administration has cleared Jazz Pharmaceuticals Plc's drug to treat a rare kind of liver disease, making it the first treatment to win U.S. approval for the condition.